Promising cancer drug trial halted early
NCT ID NCT05450562
First seen Dec 04, 2025 · Last updated May 14, 2026 · Updated 23 times
Summary
This study tested a new experimental drug called SAR444200, alone or with other cancer treatments, in 33 adults with advanced solid tumors that had spread and were no longer responding to standard therapies. The main goals were to check safety and find the right dose. However, the trial was stopped early, so we don't have full results on how well it worked.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Icahn School of Medicine at Mount Sinai- Site Number : 8400005
New York, New York, 10029, United States
-
Investigational Site Number : 1240001
Québec, Quebec, G1R 2J6, Canada
-
Investigational Site Number : 1240002
Toronto, Ontario, M5G 2M9, Canada
-
Investigational Site Number : 1560001
Shanghai, 200120, China
-
Investigational Site Number : 1560002
Wuhan, 430022, China
-
Investigational Site Number : 4100001
Seoul, Seoul-teukbyeolsi, 06351, South Korea
-
Investigational Site Number : 4100002
Seoul, Seoul-teukbyeolsi, 05505, South Korea
-
Investigational Site Number : 7020001
Singapore, 308433, Singapore
-
Investigational Site Number : 7020002
Singapore, 119074, Singapore
-
Investigational Site Number : 7020003
Singapore, 169610, Singapore
-
Lifespan Corporation- Site Number : 8400002
Providence, Rhode Island, 02903, United States
-
The University of Texas MD Anderson Cancer Center- Site Number : 8400003
Houston, Texas, 77030, United States
-
USC Norris Comprehensive Cancer Center- Site Number : 8400004
Los Angeles, California, 90033, United States
Conditions
Explore the condition pages connected to this study.